# A Study to Evaluate FK778 in Kidney Transplant Patients

> **NCT00189735** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 364 (actual)

## Conditions studied

- Kidney Transplantation
- Renal Transplantation
- Transplantation, Renal
- Transplantation, Kidney
- Grafting, Kidney

## Interventions

- **DRUG:** FK778

## Key facts

- **NCT ID:** NCT00189735
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 364 (ACTUAL)
- **Last updated:** 2008-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189735, "A Study to Evaluate FK778 in Kidney Transplant Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00189735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*